Pupil Dilation for Treatment of IFIS

Completed · Phase 2

Conditions studied: Intraoperative Floppy Iris Syndrome

In brief

A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.

Key facts

Study ID

NCT03760185

Run by

Denver Health and Hospital Authority

People needed

13

Starts

2019-01-04

Expected to finish

2020-09-25

Last updated by the study team

2022-04-20

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (18 years old or greater) 3. History of having taken, or currently taking any systemic alpha blocker 2. Ability to consent themselves 3. Ability to apply eye drops themselves TID for 7 days

You may not qualify if…

• Subjects with untreated hypertension or baseline BP >160
• Subjects with Thyrotoxicosis
• Pregnant women or women trying to conceive
• Prisoners
• Inability consent
• Subjects with anatomical narrow angles or who have never had a dilated eye exam
• Subjects currently prescribed brimonidine tartrate for glaucoma
• Subjects who take topical or systemic alpha agonists
• Patients who take monoamine oxidase (MAO) inhibitors
• Patients with known severe cardiovascular disease

Where it is running

• Denver Health — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.